89bio Inc. (NASDAQ: ETNB) on January 24, 2023, started off the session at the price of $12.29, plunging -2.52% from the previous trading day. During the day, the shares moved up to $12.6421 and dropped to $11.93 before settling in for the closing price of $12.29. Within the past 52 weeks, ETNB’s price has moved between $2.00 and $12.95.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
The company achieved an average annual earnings per share of -45.70%. With a float of $46.17 million, this company’s outstanding shares have now reached $47.25 million.
Considering the fact that the conglomerate employs 41 people, you should pay attention to its efficiency factor.
89bio Inc. (ETNB) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of 89bio Inc. is 0.90%, while institutional ownership is 89.30%. The most recent insider transaction that took place on Jan 03, was worth 74,397. In this transaction Chief Financial Officer of this company sold 5,947 shares at a rate of $12.51, taking the stock ownership to the 36,368 shares. Before that another transaction happened on Oct 18, when Company’s Director bought 1,172,741 for $7.65, making the entire transaction worth $8,971,469. This insider now owns 8,955,410 shares in total.
89bio Inc. (ETNB) Recent Fiscal highlights
As on 6/29/2022, Multinational firm has announced its last quarter scores, in which it reported -$1.23 earnings per share (EPS) for the period falling under the consensus outlook (set at -$1.05) by -$0.18. This company achieved a return on equity of -54.80. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.84 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -45.70% per share during the next fiscal year.
89bio Inc. (NASDAQ: ETNB) Trading Performance Indicators
89bio Inc. (ETNB) is currently performing well based on its current performance indicators. A quick ratio of 5.80 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.35, a number that is poised to hit -0.69 in the next quarter and is forecasted to reach -2.79 in one year’s time.
Technical Analysis of 89bio Inc. (ETNB)
Compared to the last year’s volume of 0.89 million, its volume of 1.06 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 85.77%. Additionally, its Average True Range was 0.92.
During the past 100 days, 89bio Inc.’s (ETNB) raw stochastic average was set at 88.86%, which indicates a significant increase from 67.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.37% in the past 14 days, which was lower than the 86.43% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.07, while its 200-day Moving Average is $5.96. Nevertheless, the first resistance level for the watch stands at $12.44 in the near term. At $12.90, the stock is likely to face the second major resistance level. The third major resistance level sits at $13.15. If the price goes on to break the first support level at $11.73, it is likely to go to the next support level at $11.47. Now, if the price goes above the second support level, the third support stands at $11.01.
89bio Inc. (NASDAQ: ETNB) Key Stats
Market capitalization of the company is 535.63 million based on 46,537K outstanding shares. Right now, sales total 0 K and income totals -90,120 K. The company made 0 K in profit during its latest quarter, and -26,805 K in sales during its previous quarter.